Neuronetics (STIM) filed an 8-K on November 4, 2025, detailing Q3 2025 results and executive transition plans.
CEO Succession: President and CEO Keith J. Sullivan announced his intent to retire effective June 30, 2026. A search for a successor is ongoing, and Sullivan will consult during the transition period.
Q3 2025 Financial Results: Total revenue was \(37.3M, marking 11% adjusted pro forma growth year-over-year. Greenbrook clinic revenue contributed \)21.8M, showing 25% adjusted pro forma growth. Gross margin compressed to 45.9% following the integration of the Greenbrook TMS clini
...